BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37365004)

  • 1. Bone dysplasia in Hutchinson-Gilford progeria syndrome is associated with dysregulated differentiation and function of bone cell populations.
    Cabral WA; Stephan C; Terajima M; Thaivalappil AA; Blanchard O; Tavarez UL; Narisu N; Yan T; Wincovitch SM; Taga Y; Yamauchi M; Kozloff KM; Erdos MR; Collins FS
    Aging Cell; 2023 Sep; 22(9):e13903. PubMed ID: 37365004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Hutchinson-Gilford progeria mutation during osteoblast development results in loss of osteocytes, irregular mineralization, and poor biomechanical properties.
    Schmidt E; Nilsson O; Koskela A; Tuukkanen J; Ohlsson C; Rozell B; Eriksson M
    J Biol Chem; 2012 Sep; 287(40):33512-22. PubMed ID: 22893709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
    Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
    Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
    Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
    Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects.
    Strandgren C; Nasser HA; McKenna T; Koskela A; Tuukkanen J; Ohlsson C; Rozell B; Eriksson M
    FASEB J; 2015 Aug; 29(8):3193-205. PubMed ID: 25877214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
    Moulson CL; Fong LG; Gardner JM; Farber EA; Go G; Passariello A; Grange DK; Young SG; Miner JH
    Hum Mutat; 2007 Sep; 28(9):882-9. PubMed ID: 17469202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
    Glynn MW; Glover TW
    Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation.
    Choi H; Kim TH; Jeong JK; Strandgren C; Eriksson M; Cho ES
    Sci Rep; 2018 Oct; 8(1):15368. PubMed ID: 30337599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry.
    Camafeita E; Jorge I; Rivera-Torres J; Andrés V; Vázquez J
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome.
    Ferreira-Marques M; Carvalho A; Franco AC; Leal A; Botelho M; Carmo-Silva S; Águas R; Cortes L; Lucas V; Real AC; López-Otín C; Nissan X; de Almeida LP; Cavadas C; Aveleira CA
    Aging Cell; 2023 Dec; 22(12):e13983. PubMed ID: 37858983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Macías Á; Díaz-Larrosa JJ; Blanco Y; Fanjul V; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; da Rocha AM; Ponce-Balbuena D; Allan A; Filgueiras-Rama D; Jalife J; Andrés V
    Cardiovasc Res; 2022 Jan; 118(2):503-516. PubMed ID: 33624748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell depletion in Hutchinson-Gilford progeria syndrome.
    Rosengardten Y; McKenna T; Grochová D; Eriksson M
    Aging Cell; 2011 Dec; 10(6):1011-20. PubMed ID: 21902803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
    Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
    Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
    McClintock D; Gordon LB; Djabali K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.